Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical Validation and Diagnostic Utility of Optical Genome Mapping for Enhanced Cytogenomic Analysis of Hematological Neoplasms

17 Oct 2022

Abstract excerpt

The current standard-of-care cytogenetic techniques for the analysis of hematological malignancies include karyotyping, fluorescence in situ hybridization, and chromosomal microarray, which are labor intensive and time and cost prohibitive, and they often do not reveal the genetic complexity of the tumor, demonstrating the need for alternative technology for better characterization of these tumors. Herein, we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Lymphoma Diagnosis and Treatment
Share to Viral-associated cancers and disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36265723
DOI: 10.1016/j.jmoldx.2022.09.009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical Validation and Diagnostic Utility of Optical Genome Mapping for Enhanced Cytogenomic Analysis of Hematological NeoplasmsPMID 36265723Read ↗

Optical Genome Mapping: Clinical Validation and Diagnostic Utility for Enhanced Cytogenomic Analysis of Hematological NeoplasmsSemantic proximity Read ↗

Analytic Validation of Optical Genome Mapping in Hematological MalignanciesSemantic proximity Read ↗

Clinical Validation of Optical Genome Mapping for the Detection of Structural Variations in Hematological MalignanciesSemantic proximity Read ↗

Optical Genome Mapping: A New Tool for Cytogenomic AnalysisSemantic proximity Read ↗

Optical Genome Mapping improves detection and streamlines analysis of structural variants in myeloid neoplasmsSemantic proximity Read ↗

Feasibility of Optical Genome Mapping in Cytogenetic Diagnostics of Hematological Neoplasms: A New Way to Look at DNASemantic proximity Read ↗

Clinical Utility of Optical Genome Mapping as an Additional Tool in a Standard Cytogenetic Workup in Hematological MalignanciesSemantic proximity Read ↗

Optical genome mapping for structural variation analysis in hematologic malignanciesSemantic proximity Read ↗

Optical Genome Mapping for Cytogenetic Diagnostics in AMLSemantic proximity Read ↗

Application of Optical Genome Mapping to the Risk Stratification and Treatment Optimization of Hematologic DiseasesSemantic proximity Read ↗

Optical genome mapping improves the accuracy of classification, risk stratification, and personalized treatment strategies for patients with acute myeloid leukemiaSemantic proximity Read ↗

Optical genome mapping in acute myeloid leukemia: a multicenter evaluationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.